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Objective To investigate the role ofMycobacterium avium subsp. paratuberculosis (MAP) in Crohn's disease
(CD), using short-termmycobacterial culture media.
Methods Sixty-three tissue specimens from 27  CDpatients and 36 controls were processed and inoculated
into amodi¢ed 7H9 broth base medium and incubated at 37  C and 5%CO2 for up to1year. Acid-fast
staining, determination ofmycobactin dependency, PCRanalysis using two IS900-derived
oligonucleotides and hybridizationwith an internal probewere performed.
Results MAPwas present in six of seven (86%) surgically resected tissue samples and in four of 20 (20%)
biopsies, with an overall 37% fromCDpatients, as compared to two of 36 (5.6%) of control specimens.The
presence of MAP inMycobacterial Growth IndicatorTube (MGIT) cultures was detectedwithin10^12  
weeks for surgically resected tissue and after 40  weeks for biopsy specimens, with noMAPgrowth detected
in12B* Bactec cultures.
Conclusions BecauseMAPwas present in 86% of resected tissue compared to 20% of biopsy specimens
fromCDpatients, we speculate thatMAP resides in the submucosal layer closer to the active part of the
ulcer rather than on the surface of the mucosal cells.Thus, surgically resected tissue cultured inMGIT
medium is a favorable protocol for rapid cultivation of MAPand for investigating its role in CD
pathogenesis.The data support the mycobacterial role in CDpathogenesis.
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I N T R O D U C T I O N
Crohn's disease (CD) is a gastrointestinal disorder associated
with progressive thickening of the bowelwall caused by ¢bro-
sis and narrowing of the lumen. Proliferative CD leads to
changes in the mucous membrane, giving it a cobblestone
appearance and causing varying degrees of ulceration [1, 2].
Histologically, there are granulomas and extensive lymphocy-
tic in¢ltrates in the submucosa associated with micro¢stula
formation [3]. The disease emerged perceptibly in Western
Europe and North America in the late 1940s and early 1950s.
The incidence then increased progressively in both continents
to a level which, in some areas such as northeast Scotland (11.6/
100  000 per year), now approaches that of an epidemic [4].
Granulomas and lymph node alterations in CD patients
resemble those of tuberculosis, leprosy, sarcoidosis and bovine
paratuberculosis [5^8]. Bovine paratuberculosis (also known
as Johne's disease ( JD) is a gastrointestinal disease in ruminants
and primates caused byMycobacterium avium subsp. paratubercu-
losis (MAP).The anatomic and pathologic distribution as well
as the signs and symptoms of both CD and JD are largely
shared [9]. Most recently, MAP has been identi¢ed in com-
mercial pasteurized milk, raising speculation that CD may be
associated with consumption of contaminated cattle milk
[10].
The association of MAP with CD has been investigated
more intensively in recent years. Several studies reported that a
cell-wall-de¢cient form of MAP had been isolated from tis-
sues of some CD patients instead of intact bacilli as in JD [11,
12]. These studies also reported that MAP was present in tis-
sues of CD patients to a much greater extent than in controls.
Similarly, anti-MAP antibodies have been reported to be pre-
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sent in sera fromCD patients at a higher level than in controls.
The serology studies were done using recombinant antigens
and cytoplasmic antigens from MAP [13^15]. In contrast,
some studies reported that MAPwas absent or present in some
tissues of CD patients at levels similar to those in controls [16].
Consequently, MAP's role in CD pathogenesis became con-
troversial.
Cultivation of MAP from tissue specimens, even from JD
animals, is usually associated with many obstacles. This, in
part, is because MAP is a fastidious and mycobactin-depen-
dent bacillus with a generation time of over 22  h.The sphero-
plastic form of MAP as reported in tissues from CD patients
would present more obstacles to its isolation in a culture med-
ium. In fact, cultivation of MAP spheroplasts would require
special media supplemented with additives that support the
di¡erence in the osmotic pressure between the intra- and
extracellular environments. Despite that, many studies have
reported the isolation of MAP from tissue specimens of CD
patients, but with variable percentages [17, 18]. The insertion
element IS900 has been the standard tool for genotyping the
cultured isolates either by PCR or hybridization. IS900 is an
insertion element of 1451  bp that is present in multiple copies
within the genomic DNA of MAP [19]. Additionally, the
IS900-based PCR assay has also been used to investigate
uncultured tissue from CD patients for the presence of MAP
[20]. This technique has been criticized for failing to di¡er-
entiate between viable and metabolically inactive MAP cells.
Thus, cultivation of MAP using special culture media from
tissue, followed by microscopic, mycobactin dependency and
PCR and hybridization analyses, would be the appropriate
approach to investigate the role of MAP in the pathogenesis of
CD.
The objectives of this study are to identify a culture medium
that supports the growth of the spheroplastic form of MAP
and to investigate the presence of MAP in tissue from CD
patients.
P A T I E N TS A N D M E TH O D S
Specimens and growth conditions
In total, 63 tissue specimens, from 27CDpatients (seven surgi-
cally resected tissue samples and 20 microscopic biopsies) and
36 controls (three surgically resected tissue samples and 33
microscopic biopsies from normal (N), non-speci¢c colitis
(NSC) and ulcerative colitis (UC) patients) were used in this
study (Table  1). All tissue specimens designated by a code were
collected at Florida Hospital (Orlando, Florida) and kindly
provided by Dr Ira Shafran (Florida Hospital, Orlando, Flor-
ida). Tissue specimens preserved in sterile saline were trans-
ported in a NovaChamber cooling system (NovaSense, Inc.,
Orlando, Florida, USA) to the University of Central Florida.
They were processed immediately in a Biosafety Cabinet class
II for culture analysis. One gram from surgically resected tis-
sue specimens or the entire biopsy was transferred to sterile
50-mL centrifuge tubes; this was followed by grinding with a
disposable 50-mL tube grinder (Fisher Scienti¢c, Pittsburgh,
PA, USA) for a few minutes. A volume of 5.0  mL of NACL
solution (NaOH^N-acetyl-L-cysteine) was added to the
ground tissue in the tube, as described by the manufacturer.
The tube was vortexed for 1  min and then left to stand at room
temperature for 15^20  min with occasional swirling. Phos-
phate bu¡er solution (PBS, pH  6.8) was then added to the 50-
mLmark. After thorough mixing, the tube was centrifuged at
3000  rev/min for 20  min. The supernatant was decanted and
the sediment was washed twice in1.0  mL of PBS at 10  000  rev/
min and 4  C. The washed pellet was dissolved in 1.0  mL of
PBS.Volumes of 0.5  mLwere used to inoculate one Mycobac-
terial Growth Indicator Tube (MGIT) and one 12B* Bactec
bottle (Becton Dickinson, Pittsburgh, PA, USA). Both cul-
ture media were supplemented with OADC (oleic acid,
bovine albumin, dextrose, catalase) enrichment, mycobactin J
(2  mg/L, Allied Monitor, Fayette, MO, USA) and PANTA
antibiotics mixture (polymyxin B, amphotericin B, nalidixic
acid, trimethoprim and azlocillin) as described by the manu-
facturer (Becton Dickinson). Although both culture media are
derivatives of 7H9-broth base, MGIT medium contains, in
addition, L-asparagine, pyroxidine, trace elements, biotin and
glycerol. All inoculated media were incubated at 37  C and
5% CO2. The Bactec bottles were read using the Bactec 460
TB analyzer, and the MGIT tubes were read using a 365-nm
UV-illuminator, as described by the manufacturer. All nega-
tive cultures were incubated for1year.
Identi®cation of MAP
Microscopic staining and DNA extraction
An aliquot of 1.0  mL of culture suspension was transferred to
a sterile 1.5-mL centrifuge tube. Following centrifugation at
Table  1 Summary of MAP presence in tissue specimens used in
this study
Source
Number and percentage of MAP in tissue
Biopsy
Surgically
resected Overall
Crohn's disease 4/20 (20%) 6/7 (86%) 37%
Controls 2/33 (6%) 0/3 (0%) 5.6%
Normal 1/13 (7.7%) 0/2 (0%) ±
Non-speci®c colitis 1/7 (14%) 0/0 (0%) ±
Ulcerative colitis 0/13 (0%) 0/1 (0%) ±
Total 53 10 63
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10  000  rev/min for 5  min, the supernatant was discarded and
the pellet waswashed three times with PBS (pH  6.8). Each pel-
let was suspended in 500  mL of TE bu¡er (10  mMTris; 0.1  mM
EDTA, pH  8.0) and then heated at 80  C for 10  min to deacti-
vate the cells. The sample was centrifuged at 10  000  rev/min
for 5  min and the supernatant was discarded. The cell pellet
was suspended in 150  mL of sterile distilled water. Avolume of
50  mLwas used to prepare a microscopic slide smear for stain-
ing with Kinyoun acid-fast stain [21]. The remaining volume
was used for extraction of genomic DNA for PCR analysis as
described previously [22].The cell suspension was adjusted to
200  mL with Perkin-Elmer DNA Extraction Reagent as
described by the manufacturer. The tube was heated at 56  C
for 30  min, mixed again, and then heated at 100  C for 10  min.
The cell lysate was mixed, centrifuged at 15  000  rev/min and
4  C for 3  min, and then transferred to a new tube and used
immediately for PCRor stored atÿ20  C until used.
PCR detection and southern hybridization
Each DNA extract was subjected to PCR analysis for the pre-
sence of the IS900 ampli¢ed fragment, as described previously
[22].The two oligonucleotide primers used for PCR ampli¢-
cation of a unique 400-bp region of IS900 (position 22^421)
were P90 (50GTTCGGGGCCGTCGCTTAGG-30) and P91
(50 -GAGGTCGATCGCCCACGTGA-30). The PCR reaction
consisted of 50  mL, containing 25  mL of DNAtemplate and 25  
mL of the PCR reaction mixture (20  mM Tris, 100  mM KCl
(pH  8.3), 0.6  mM each dNTP, 2  ng of each primer, 5  mM
MgCl2, and 2.5 units ofTaq polymerase). The reaction mix-
tures were then subjected to PCRampli¢cation using aRobo-
cycler Gradient 96 temp Cycler (Stratagen, La Jolla, CA,
USA). The program used included 5  min of denaturation at
95  C, followed by 35 cycles of ampli¢cation (2  min at 94  C,
2  min at 55  C and 3  min at 72  C), followed by a 10-min
extension at 72  C and a 4  C inde¢nite hold until retrieved.
Appropriate controls were used in parallel with each PCR
experiment, including a DNA template from MAP strain
ATCC 43015 as positive control. PCRproducts were analyzed
on 2.0% agarose gel following standard procedures [23]. The
gel was photographed, and the ampli¢ed fragments were then
transferred overnight onto nylon membranes (Hybond-N,
Amersham Life Science Inc., Arlington, IL, USA) by the alka-
line transfer method using 0.4 M sodium hydroxide as
described previously [22]. Hybridizationwas performed using
a speci¢c MAP probe consisting of a 251-bp DNA fragment
isolated and kindly provided by Professor Hermon-Taylor
(Department of Microbiology, University of Surrey, Guild-
ford, UK) through Dr Fouad El-Zaatari (Baylor College of
Medicine, Houston,Texas, USA).This probe, located at the 50 -
region of the insertion element IS900 at position 163^414 [22],
was labeled by the hexanucleotide priming technique with
digoxigenin-11-dUTP, using the Genius labeling kit and fol-
lowing the manufacturer's instructions (Boehringer Mann-
heim, Indianapolis, IN,USA).
R E S U L T S
Although microbial growth was observed in some cultures of
bothmedia, onlyMGITcultureswere positive for the presence
of MAP. All Bactec cultures were negative for the presence of
MAP during the course of this study. Overall, MAP was pre-
sent and con¢rmed in 10 of 27 (37%) CD tissue specimens (6/
7 (86%) surgically resected tissue specimens and 4/20 (20%)
of the biopsies), compared to two of 36 (5.6%) controls (2/33
(6%) biopsies and none in the three resected tissue specimens),
as summarized inTable  1. Positive cultures for MAPwere con-
¢rmed to be acid-fast positive and mycobactin dependent
when subcultured in the presence and absence of mycobactin J.
Figure  1shows one of the acid-fast-positive cultures from early
cultivation of CD resected tissue specimens. Interestingly, two
forms of MAP were observed: the prespheroplast formwith a
partial cell wall compartment (Figure 1A) and the bacillus
intact cell form (Figure1B). Additionally, and as shown in Fig-
ure 2, a 400-bp ampli¢ed PCR fragment from IS900 analyzed
on 2% agarose gel was present in six of seven resected tissue
specimens from CD patients (lanes 3^9) and not in resected
Figure  1 Microscopic analysis of short-term culture of a
resected tissue specimen from a CD patient. Acid-fast stain
was performed on a culture sample obtained following short-
term incubation of processed CD tissue. (A) Corresponds to
the prespheroplastic form of MAP with partial cell wall materi-
als. (B) Corresponds to the intact bacillus form of MAP.
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tissue from the controls (lanes 10^12). The speci¢city of the
fragment was con¢rmed by hybridization using the 251-bp
internal probe (data not shown).The presence of MAP in posi-
tive cultures was recon¢rmed independently by Dr William
Safranek at Wousheo¡ Hospital Rocklege, Florida using the
p90 and p91oligonucleotide primers.
D I S C U S S I O N
Most published reports related to proving or disproving the
association of MAP with CD have been based on identi¢ca-
tion of MAP in tissue specimens or anti-MAP antibodies in
sera from CD patients. MAP isolated from tissues of CD
patients has been reported following long-term incubation of
cultured tissue. In some studies, 2 years of incubation was
needed before cultures became positive for MAP. The out-
comes of experiments that require 2 years of incubation may
be altered by factors such as dehydration of media, malfunc-
tion of instrumentation and poor follow-up by the investiga-
tor. Consequently, false-negative results will be reported.
Despite that, MAPwas isolated from and con¢rmed to be pre-
sent in tissues of some CD patients. Speci¢cally, the positive
cultures were reported as being from cultured surgically
resected tissue. The study described in this paper aimed to
identify culture media for the rapid isolation of MAP and to
investigate surgically resected tissue versus microscopic biop-
sies for the determination of the presence of MAP in CD
patients. Ultimately, is MAP present in tissues of CD patients?
Bactec 12B* and MGIT culture media have been reported to
be successful in primary isolation ofMycobacterium avium com-
plex (MAC) from clinical specimens.The data as summarized
in Table  1 indicate that MAP is present in tissue specimens
from CD patients (37%) at higher levels than in controls
(5.6%).This alone con¢rms previous data that support the role
of MAP in CD pathogenesis. Interestingly, the data illustrated
in Figure 2 demonstrate that MAP is present in 86% of surgi-
cally resected tissue compared to 20% of biopsy specimens of
CD patients compared to 0% of controls. These data suggest
thatMAPmay be residing in the submucosal layer of ulcerated
tissue in CD patients rather than in biopsies obtained from the
surface of the mucosal layer. The fact that MAP was cultured
in several weeks from resected tissue of CD patients, rather
than several months as seen in some positive biopsies, may
indicate that MAP in deep tissue is virulent and metabolically
active. On the other hand, MAP on the surface of the mucosal
layer may be avirulent with inactive metabolic status. This
may explainwhy some controls may be positive forMAPafter
long-term incubation. Consequently, we propose that using
surgically resected tissue may be more appropriate for investi-
gating the association of MAP with CD etiology.We suggest
that the MGITmedium is more appropriate for cultivation of
MAP from clinical specimens.This may be related to the extra
additives in MGITmedium. In fact, these additives are known
to bemore supportive of cell di¡erentiation and division.
The two positive control biopsies were from a normal
healthy individual and from a patient with non-speci¢c coli-
tis. The presence of MAP in the two positive control samples
was con¢rmed as those from CD samples. These two MAP
isolates will be analyzed in a future study for epidemiologic
and virulence markers, along with those from CD biopsies
and surgically resected tissue specimens.The diagnosis of non-
speci¢c colitis may sometimes be misleading. It is interpreted
by some physicians as being borderline with Crohn's disease.
Therefore, there is a chance that one of our positive control
specimens may be from an actual CDpatient.
The acid-fast stain on positiveMAPcultures was performed
at di¡erent stages of the incubation. It was noted early in the
culture incubation that spheroplastic forms of MAP were
reverting to the bacillus form. This was con¢rmed when the
bacillus form became more dominant in the culture following
Figure  2 IS900±PCR detection of MAP from surgically resected tissue cultured in MGIT media. PCR products were analyzed on
2.0% agarose gel. Lane 1 represents DNA from MAP strain 43015. Lane 2 has no DNA. Lanes 3±9 represent resected tissue from
CD patients. Lanes 10±12 represent tissue from controls. M is the molecular weight marker in base pairs (bp).
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further incubation. As shown in Figure 1, a spheroplastic
form of MAP (A) with partial cell wall materials was
observed, compared to the remainder of the culture, which
contained the bacillus form (B). This, in turn, con¢rms pre-
vious reports suggesting that the spheroplastic form is the
virulent formof MAP in CDpathogenesis [11,12,19].
The presence of MAP in tissues of CD patients has been
con¢rmed. A protocol describing the culture media and the
types of specimen for investigatingMAP's role in CDhas been
described.
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